In Vitro-In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug-Drug Interactions-Overview of Basic Prediction Methods

Kenta Yoshida, Ping Zhao, Lei Zhang, Darrell R. Abernethy, Dinko Rekić, Kellie S. Reynolds, Aleksandra Galetin, Shiew Mei Huang

Research output: Research - peer-reviewArticle

Abstract

Evaluation of drug-drug interaction (DDI) risk is vital to establish benefit-risk profiles of investigational new drugs during drug development. In vitro experiments are routinely conducted as an important first step to assess metabolism- and transporter-mediated DDI potential of investigational new drugs. Results from these experiments are interpreted, often with the aid of in vitro-in vivo extrapolation methods, to determine whether and how DDI should be evaluated clinically to provide the basis for proper DDI management strategies, including dosing recommendations, alternative therapies, or contraindications under various DDI scenarios and in different patient population. This article provides an overview of currently available in vitro experimental systems and basic in vitro-in vivo extrapolation methodologies for metabolism- and transporter-mediated DDIs.

LanguageEnglish (US)
JournalJournal of Pharmaceutical Sciences
DOIs
StateAccepted/In press - 2017

Fingerprint

Drug Interactions
Pharmaceutical Preparations
In Vitro Techniques
Investigational Drugs
Drug Evaluation
Complementary Therapies
Population

Keywords

  • Cytochrome P450s
  • Drug interaction
  • Guidance/guideline
  • Membrane transport/transporters
  • Regulatory

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmaceutical Science

Cite this

In Vitro-In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug-Drug Interactions-Overview of Basic Prediction Methods. / Yoshida, Kenta; Zhao, Ping; Zhang, Lei; Abernethy, Darrell R.; Rekić, Dinko; Reynolds, Kellie S.; Galetin, Aleksandra; Huang, Shiew Mei.

In: Journal of Pharmaceutical Sciences, 2017.

Research output: Research - peer-reviewArticle

Yoshida, Kenta ; Zhao, Ping ; Zhang, Lei ; Abernethy, Darrell R. ; Rekić, Dinko ; Reynolds, Kellie S. ; Galetin, Aleksandra ; Huang, Shiew Mei. / In Vitro-In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug-Drug Interactions-Overview of Basic Prediction Methods. In: Journal of Pharmaceutical Sciences. 2017
@article{20558571eaf843adb944375c20994bdc,
title = "In Vitro-In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug-Drug Interactions-Overview of Basic Prediction Methods",
abstract = "Evaluation of drug-drug interaction (DDI) risk is vital to establish benefit-risk profiles of investigational new drugs during drug development. In vitro experiments are routinely conducted as an important first step to assess metabolism- and transporter-mediated DDI potential of investigational new drugs. Results from these experiments are interpreted, often with the aid of in vitro-in vivo extrapolation methods, to determine whether and how DDI should be evaluated clinically to provide the basis for proper DDI management strategies, including dosing recommendations, alternative therapies, or contraindications under various DDI scenarios and in different patient population. This article provides an overview of currently available in vitro experimental systems and basic in vitro-in vivo extrapolation methodologies for metabolism- and transporter-mediated DDIs.",
keywords = "Cytochrome P450s, Drug interaction, Guidance/guideline, Membrane transport/transporters, Regulatory",
author = "Kenta Yoshida and Ping Zhao and Lei Zhang and Abernethy, {Darrell R.} and Dinko Rekić and Reynolds, {Kellie S.} and Aleksandra Galetin and Huang, {Shiew Mei}",
year = "2017",
doi = "10.1016/j.xphs.2017.04.045",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - In Vitro-In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug-Drug Interactions-Overview of Basic Prediction Methods

AU - Yoshida,Kenta

AU - Zhao,Ping

AU - Zhang,Lei

AU - Abernethy,Darrell R.

AU - Rekić,Dinko

AU - Reynolds,Kellie S.

AU - Galetin,Aleksandra

AU - Huang,Shiew Mei

PY - 2017

Y1 - 2017

N2 - Evaluation of drug-drug interaction (DDI) risk is vital to establish benefit-risk profiles of investigational new drugs during drug development. In vitro experiments are routinely conducted as an important first step to assess metabolism- and transporter-mediated DDI potential of investigational new drugs. Results from these experiments are interpreted, often with the aid of in vitro-in vivo extrapolation methods, to determine whether and how DDI should be evaluated clinically to provide the basis for proper DDI management strategies, including dosing recommendations, alternative therapies, or contraindications under various DDI scenarios and in different patient population. This article provides an overview of currently available in vitro experimental systems and basic in vitro-in vivo extrapolation methodologies for metabolism- and transporter-mediated DDIs.

AB - Evaluation of drug-drug interaction (DDI) risk is vital to establish benefit-risk profiles of investigational new drugs during drug development. In vitro experiments are routinely conducted as an important first step to assess metabolism- and transporter-mediated DDI potential of investigational new drugs. Results from these experiments are interpreted, often with the aid of in vitro-in vivo extrapolation methods, to determine whether and how DDI should be evaluated clinically to provide the basis for proper DDI management strategies, including dosing recommendations, alternative therapies, or contraindications under various DDI scenarios and in different patient population. This article provides an overview of currently available in vitro experimental systems and basic in vitro-in vivo extrapolation methodologies for metabolism- and transporter-mediated DDIs.

KW - Cytochrome P450s

KW - Drug interaction

KW - Guidance/guideline

KW - Membrane transport/transporters

KW - Regulatory

UR - http://www.scopus.com/inward/record.url?scp=85020628466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020628466&partnerID=8YFLogxK

U2 - 10.1016/j.xphs.2017.04.045

DO - 10.1016/j.xphs.2017.04.045

M3 - Article

JO - Journal of Pharmaceutical Sciences

T2 - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

ER -